About the Cuban Human Brain Mapping Project (CHBMP)

Published in Research Data

About the Cuban Human Brain Mapping Project (CHBMP)
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

We explain the background of https://rdcu.be/ceOYo. This is the MRI, EEG, and clinical data from the second wave of the CHBMP, now  openly available. The first wave data (only EEG cross-spectra) was also published (Frontiers in neuroscience. 2020;14). With a long history of modeling and close work with the Public Health, the Cuban Brain Mapping community overcame limitations in resources due to equipment unavailability. We countered this obstacle by an effective integration with the family doctors. We hope with the publication of this data and its hosting on the Canadian Open Neuroinformatics Platform in LORS) to achieve comparions with similar international databases, with emphasis in underepresented regionso  f the world. As part of the Cuba-China-Canada Project and the Global Braain Consoritum, we wish to inegrate clinical and multimodal neuroimaging data. The inclusion of EEG is intentded to develop bridges between more sophisticated brain imaging technologies and less expensive ones. We thus hope to foster technologies for use in all economic settings. 

Follow the Topic

Research Data
Research Communities > Community > Research Data

Related Collections

With Collections, you can get published faster and increase your visibility.

10 years of the FAIR principles

This Scientific Data Collection invites researchers to submit manuscripts related to FAIR-aligned infrastructure, policy, or standardisation.

Publishing Model: Open Access

Deadline: Nov 14, 2026

Data to support cancer treatment, diagnosis, and disease understanding

This Scientific Data collection welcomes descriptions of any dataset relevant to cancer research, including ’omics data; in vitro, in vivo, in silico, and human studies; early‑phase drug discovery data; as well as larger cohort and population‑level datasets related to measuring outcomes and disease occurrence at large scales.

Publishing Model: Open Access

Deadline: Jan 02, 2027